Folia Medica (Jun 2018)
Treatment of Childhood Acute Myeloid Leukemia in Bulgaria
- Burnusuzov Hasan A.,
- Yordanova Maya N.,
- Avramova Boryana E.,
- Yurukova Nadezhda N.,
- Bachvarov Konstantin N.,
- Muchinova Albena B.,
- Vlahova Irena H.,
- Stoyanova Angelina A.,
- Mumdzhiev Ivan N.,
- Ivanova Liliya R.,
- Spasov Neofit Y.,
- Peteva Elina Ts.,
- Belcheva Milena I.,
- Hristozova Hristina,
- Spasova Mariya I.,
- Kaleva Valeriya I.,
- Bobev Dragan,
- Konstantinov Dobrin N.
Affiliations
- Burnusuzov Hasan A.
- Department of Pediatrics and Medical Genetics, Medical University of Plovdiv, Plovdiv, Bulgaria
- Yordanova Maya N.
- Clinic of Children’s Oncohematology and Transplantation, Queen Johanna University Hospital - ISUL, Sofia, Bulgaria
- Avramova Boryana E.
- Clinic of Children’s Oncohematology and Transplantation, Queen Johanna University Hospital - ISUL, Sofia, Bulgaria
- Yurukova Nadezhda N.
- Clinic of Children’s Oncohematology and Transplantation, Queen Johanna University Hospital - ISUL, Sofia, Bulgaria
- Bachvarov Konstantin N.
- Clinic of Children’s Oncohematology and Transplantation, Queen Johanna University Hospital - ISUL, Sofia, Bulgaria
- Muchinova Albena B.
- Clinic of Children’s Oncohematology and Transplantation, Queen Johanna University Hospital - ISUL, Sofia, Bulgaria
- Vlahova Irena H.
- Clinic of Children’s Oncohematology and Transplantation, Queen Johanna University Hospital - ISUL, Sofia, Bulgaria
- Stoyanova Angelina A.
- Department of Pediatrics and Medical Genetics, Medical University of Plovdiv, Plovdiv, Bulgaria
- Mumdzhiev Ivan N.
- Department of Pediatrics and Medical Genetics, Medical University of Plovdiv, Plovdiv, Bulgaria
- Ivanova Liliya R.
- Department of Pediatrics and Medical Genetics, Medical University of Plovdiv, Plovdiv, Bulgaria
- Spasov Neofit Y.
- Department of Pediatrics and Medical Genetics, Medical University of Plovdiv, Plovdiv, Bulgaria
- Peteva Elina Ts.
- Department of Pediatrics and Medical Genetics, Medical University, Varna, Bulgaria
- Belcheva Milena I.
- Department of Pediatrics and Medical Genetics, Medical University, Varna, Bulgaria
- Hristozova Hristina
- Department of Pediatrics and Medical Genetics, Medical University, Varna, Bulgaria
- Spasova Mariya I.
- Department of Pediatrics and Medical Genetics, Medical University of Plovdiv, Plovdiv, Bulgaria
- Kaleva Valeriya I.
- Department of Pediatrics and Medical Genetics, Medical University, Varna, Bulgaria
- Bobev Dragan
- Clinic of Children’s Oncohematology and Transplantation, Queen Johanna University Hospital - ISUL, Sofia, Bulgaria
- Konstantinov Dobrin N.
- Clinic of Children’s Oncohematology and Transplantation, Queen Johanna University Hospital - ISUL, Sofia, Bulgaria
- DOI
- https://doi.org/10.1515/folmed-2017-0090
- Journal volume & issue
-
Vol. 60,
no. 2
pp. 234 – 240
Abstract
Background: During the last four decades the prognosis of childhood acute myeloid leukemia (AML) has been substantially improved due to an increase in complete remission (CR) rates, event-free survival (EFS) and reduced early mortality. The relapsed AML still remains a therapeutic challenge.
Keywords
